By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akebia Therapeutics, Inc. 

9987 Carver Road
Suite 420
Cincinnati  Ohio  45242  U.S.A.
Phone: 513-618-0931 Fax: 513-618-0950


Company News
Akebia (AKBA) Announces Publication Highlighting Potential Benefits Of HIF Treatments For Patients With Renal Anemia 9/26/2016 10:50:16 AM
Akebia (AKBA) Announces Publication Of Phase IIb Data For Vadadustat In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease 9/19/2016 11:18:35 AM
Akebia (AKBA) To Present At Upcoming Investor Conferences 9/7/2016 12:56:51 PM
Akebia (AKBA) Announces Publication Highlighting Need For New Solutions In Treating Dialysis Patients 8/22/2016 9:00:24 AM
Akebia (AKBA) Announces Second Quarter 2016 Financial Results 8/9/2016 10:58:55 AM
Akebia (AKBA) Initiates INNO2VATE Phase 3 Program For Vadadustat In Dialysis Patients With Anemia Related To Chronic Kidney Disease 8/9/2016 10:24:49 AM
Akebia (AKBA) Appoints Scott A. Canute To Its Board Of Directors 8/3/2016 11:43:27 AM
Akebia (AKBA) To Present At The Cantor Fitzgerald Annual Healthcare Conference 7/6/2016 8:48:20 AM
Akebia (AKBA) Announces Positive Vadadustat Data Demonstrating No Clinically Significant Drug-Drug Interaction 5/23/2016 9:30:29 AM
Akebia (AKBA) To Present At The 2016 UBS Global Healthcare Conference 5/16/2016 10:10:27 AM